The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GSK plc (LON:GSK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,444 ($18.73) and traded as high ...
GlaxoSmithKline share price surged 27% in one month and over 17% on a year-to-date (YTD) basis. The stock has fallen 10% in six months, but has risen 16% in one year. However, over the past two ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
Rather than solely betting on a bounce or trend reversal in the broader index, look to stocks like Castrol India, ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
Price Action: GSK stock is up 2.55% at $38.92 at the last check Tuesday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results